University of Toronto researchers get to the heart of heart failure

June 19, 2002

Researchers at the University of Toronto and the University Health Network have identified two genes that play critical roles in heart function - one that contributes to heart failure and one that protects against it.

"This finding is really amazing because it opens up new avenues for the treatment of cardiovascular diseases and heart failure," says Professor Josef Penninger of U of T's medical biophysics and immunology departments and lead author of a study in the June 20 issue of Nature. He and colleague Dr. Peter Backx, a physiology and medicine professor at U of T's Heart & Stroke/Richard Lewar Centre, found that when both genes - angiotensin converting enzyme (ACE) 1 and 2 - are in balance in mice models, the animals developed healthy hearts.

The researchers initially began the study by looking for genes that controlled heart development in flies. Intrigued by finding that the fly's ACE 2 gene is essential in the development of fly hearts, they broadened the study and look for the role of ACE 2 in rats that develop hypertension and cardiovascular disease.

Using genetically-engineered mice, the researchers found that mice carrying the ACE 1 but not ACE 2 gene developed cardiovascular disease and impaired heart function. It is known that ACE 1 serves an important cardiovascular function by generating certain hormones that cause blood vessels to constrict, which helps the body maintain proper blood pressure. The new study by the Toronto team, however, offers a completely new concept for heart function. ACE 1 by-products may regulate blood pressure and control heart function, but if unchecked, they also can contribute to the progression of heart disease, coronary artery disease and heart failure.

"This is the first time that scientists have been able to show that the ACE 1 enzyme is a critical contributor to the inability of the heart to function optimally. Perhaps even more important, we've also shown that the ACE 2 gene plays a highly protective role in heart function by counteracting the negative effects of ACE 1 by-products," says Penninger.

ACE 2 appears to produce its beneficial effects on the heart by preventing the actions of peptide hormones generated by ACE 1, says Backx, a heart disease specialist. "This research solidifies the view that the protective effects of ACE 1 inhibitors (drugs now commonly prescribed for patients with hypertension, cardiovascular disease and coronary heart disease) work by directly interfering with the production of these peptide hormones generated by ACE 1 enzymes. Up to now, nobody knew how this system worked."

Unfortunately, while ACE 1 inhibitors do help slow the progression of heart disease, they are not always effective and their current use is often limited by side effects, Backx says. "But if we understand the connection between peptides and ACE inhibitors, we can begin to tailor the drugs to be much more specific."

The researchers say the study establishes the fact that ACE 2 plays a fundamental role in the cardiovascular system of rats, mice and flies, which strongly suggests the gene is also an important regulator of cardiovascular function in humans. "What I found interesting is that the hearts in our mice looked like human ones with coronary heart disease," says Penninger. "The transgenic mouse models created in these studies can now be used to develop new approaches to heart disease therapy and new approaches for genetic screening if people are at risk for heart disease and heart failure."

Hypertension is a disease that afflicts over 25 per cent of the population aged 45 and older. Left unchecked, it leads to heart attacks, stroke, coronary artery disease and heart failure. Collectively, cardiovascular disease is now recognized as the major cause of death and disease in modern societies. Despite recent predictions that death from cardiovascular disease will be the world's number one killer within the next 10 years, the genetics and mechanisms of heart disease are poorly understood.

The study was performed at the University Health Network by Michael Crackower, a post-doctoral fellow in Penninger's lab, and at U of T by Gavin Oudit, a clinician scientist in Brackx's lab. The lead researchers also received assistance from U of T researchers Armen Manoukian and York Pei, Chana Yagil and Yoram Yagil of Ben-Gurion University in Israel and Mark Chappell and Carlos Ferrario of Wake Forest University in North Carolina.
-end-
This research was supported by AMGEN Inc., the Institute for Molecular Biotechnology of the Austrian Academy of Sciences, the Canadian Institutes of Health Research, and the Heart and Stroke Foundation of Ontario.

University of Toronto

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.